key: cord-0846653-fk051zz4
authors: Perna, Danielle; Jones, Jordan; Schadt, Courtney R.
title: Acute generalized pustular psoriasis exacerbated by the COVID-19 vaccine
date: 2021-09-09
journal: JAAD Case Rep
DOI: 10.1016/j.jdcr.2021.08.035
sha: acf284e1af1277d99e44e7b747841fc7a2d9488f
doc_id: 846653
cord_uid: fk051zz4

nan

Acute generalized exanthematous pustulosis (AGEP) from bupropion must also be considered in 76 the differential. 3 AGEP, however, develops within 1-2 days following exposure to the causative 77 drug and quickly resolves with withdrawal of the medication, in contrast to AGPP, which, 78 typically develops within 2-7 weeks following consumption of the responsible drug . 4 

Generalized pustular psoriasis: a 113 review and update on treatment

Psoriasis Flares Following Systemic 116

Glucocorticoid Exposure in Patients with a History of Psoriasis

Bupropion-induced acute generalized exanthematous pustulosis

Acute Generalized Exanthematous Pustulosis

Clinical Variants and Therapy

Generalized Pustular Cutaneous Reaction As a New Clinical Entity: A Case 130

Cutaneous reactions reported after 134

Moderna and Pfizer COVID-19 vaccination: A registry-based study of 414 cases

Psoriatic skin lesions induced by BCG 138 vaccination

Psoriasis triggered by tetanus-diphtheria vaccination. Cutaneous 142 and Ocular Toxicology

Stress-induced enhancement of leukocyte trafficking into 146 sites of surgery or immune activation

A generalized pustular psoriasis flare after 149

CoronaVac COVID-19 vaccination: Case report. Health promotion perspectives